Bafna Pharmaceuticals Ltd vs Roopa Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 137 as of 04 May 15:30 . The P/E Ratio of Bafna Pharmaceuticals Ltd changed from 55.8 on March 2021 to 42.6 on March 2025 . This represents a CAGR of -5.26% over 5 yearsThe P/E Ratio of Roopa Industries Ltd changed from 10.3 on March 2021 to 19.8 on March 2025 . This represents a CAGR of 13.96% over 5 years The Market Cap of Bafna Pharmaceuticals Ltd changed from ₹ 324.8 crore on March 2021 to ₹ 177.42 crore on March 2025 . This represents a CAGR of -11.39% over 5 yearsThe Market Cap of Roopa Industries Ltd changed from ₹ 7.36 crore on March 2021 to ₹ 40.25 crore on March 2025 . This represents a CAGR of 40.47% over 5 years The revenue of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 39.51 crore as compare to the Sep '25 revenue of ₹ 36.65 crore. This represent the growth of 7.8% The revenue of Roopa Industries Ltd for the Dec '25 is ₹ 33.54 crore as compare to the Sep '25 revenue of ₹ 28.75 crore. This represent the growth of 16.66% The ebitda of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 4.27 crore as compare to the Sep '25 ebitda of ₹ 5.46 crore. This represent the decline of -21.79% The ebitda of Roopa Industries Ltd for the Dec '25 is ₹ 2.03 crore as compare to the Sep '25 ebitda of ₹ 1.64 crore. This represent the growth of 23.78% The net profit of Bafna Pharmaceuticals Ltd changed from ₹ -0.72 crore to ₹ 1.84 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Roopa Industries Ltd changed from ₹ 0.27 crore to ₹ 0.77 crore over 7 quarters. This represents a CAGR of 82.00% The Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Roopa Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and is engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non Betalactum products.
The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

About Roopa Industries Ltd

Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries.
The Company was incorporated in 1985 and operates into manufacturing and marketing of bulk drugs and intermediaries.
The Company became a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.
Over the years, it has been a principal supplier to many companies in various countries. The Company handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations.
It offers triphenyl phosphine for use as wittig reagent in the manufacture of pharmaceuticals and cosmetics; as catalyst in hydroformylation, isomerisation, and polymerisation of olefins; as catalysing and curing agent in a range of polymerization reactions, epoxy resins, and photopolymers; and as reducing and deoxygenating agent in quinones, epoxides, amine oxides, and sulfoxides.

FAQs for the comparison of Bafna Pharmaceuticals Ltd and Roopa Industries Ltd

Which company has a larger market capitalization, Bafna Pharmaceuticals Ltd or Roopa Industries Ltd?

Market cap of Bafna Pharmaceuticals Ltd is 324 Cr while Market cap of Roopa Industries Ltd is 46 Cr

What are the key factors driving the stock performance of Bafna Pharmaceuticals Ltd and Roopa Industries Ltd?

The stock performance of Bafna Pharmaceuticals Ltd and Roopa Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bafna Pharmaceuticals Ltd and Roopa Industries Ltd?

As of May 5, 2026, the Bafna Pharmaceuticals Ltd stock price is INR ₹137.0. On the other hand, Roopa Industries Ltd stock price is INR ₹59.0.

How do dividend payouts of Bafna Pharmaceuticals Ltd and Roopa Industries Ltd compare?

To compare the dividend payouts of Bafna Pharmaceuticals Ltd and Roopa Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.